Immunosuppression of Syrian golden hamsters accelerates relapse but not the emergence of resistance in Leishmania infantum following recurrent miltefosine pressure

Although miltefosine (MIL) has only been approved for the treatment of visceral leishmaniasis (VL) in 2002, its application in monotherapy already led to the development of two confirmed MIL-resistant isolates by 2009. Although liposomal amphotericin B is recommended as first-line treatment in Europ...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Parasitol Drugs Drug Resist
Main Authors: Hendrickx, S., Bulté, D., Van den Kerkhof, M., Cos, P., Delputte, P., Maes, L., Caljon, G.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6296292/
https://ncbi.nlm.nih.gov/pubmed/30562667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2018.12.001
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki